These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 38583756

  • 1. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Edmonston D, Fuchs MAA, Burke EJ, Isakova T, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    Am J Kidney Dis; 2024 Sep; 84(3):349-360.e1. PubMed ID: 38583756
    [Abstract] [Full Text] [Related]

  • 2. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y, Olauson H, Vavilis G, Hammar U, Herthelius M, Axelsson J, Bárány P.
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [Abstract] [Full Text] [Related]

  • 3. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.
    BMJ Open; 2017 Aug 23; 7(8):e016528. PubMed ID: 28838895
    [Abstract] [Full Text] [Related]

  • 4. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Correa S, Pena-Esparragoza JK, Scovner KM, Waikar SS, Mc Causland FR.
    Am J Kidney Dis; 2020 Jul 23; 76(1):32-41. PubMed ID: 31864821
    [Abstract] [Full Text] [Related]

  • 5. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH.
    Am J Kidney Dis; 2013 Jun 23; 61(6):899-909. PubMed ID: 23540260
    [Abstract] [Full Text] [Related]

  • 6. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA, Eisenga MF, van Ballegooijen AJ, Beulens JWJ, Vervloet MG, Navis G, Gansevoort RT, Bakker SJL, De Borst MH.
    Nephrol Dial Transplant; 2021 Jan 01; 36(1):121-128. PubMed ID: 32124925
    [Abstract] [Full Text] [Related]

  • 7. Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.
    Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G, FRENCH Study collaborators.
    Clin J Am Soc Nephrol; 2017 Dec 07; 12(12):1930-1940. PubMed ID: 29074818
    [Abstract] [Full Text] [Related]

  • 8. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb 07; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E, Thodis E, Arsos G, Pasadakis P, Panagoutsos S, Papadopoulou D, Papagianni A.
    Kidney Blood Press Res; 2020 Feb 07; 45(6):900-915. PubMed ID: 33040068
    [Abstract] [Full Text] [Related]

  • 10. Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ishigami J, Kansal M, Mehta R, Srivastava A, Rahman M, Dobre M, Al-Kindi SG, Go AS, Navaneethan SD, Chen J, He J, Bhat ZY, Jaar BG, Appel LJ, Matsushita K, CRIC Study Investigators.
    Am J Kidney Dis; 2023 Aug 07; 82(2):225-236. PubMed ID: 36935072
    [Abstract] [Full Text] [Related]

  • 11. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, Rahman M, CRIC Investigators.
    Am J Kidney Dis; 2013 Oct 07; 62(4):670-8. PubMed ID: 23489677
    [Abstract] [Full Text] [Related]

  • 12. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
    Seiler S, Rogacev KS, Roth HJ, Shafein P, Emrich I, Neuhaus S, Floege J, Fliser D, Heine GH.
    Clin J Am Soc Nephrol; 2014 Jun 06; 9(6):1049-58. PubMed ID: 24677555
    [Abstract] [Full Text] [Related]

  • 13. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1989-1998. PubMed ID: 27561289
    [Abstract] [Full Text] [Related]

  • 14. Association of Longitudinal B-Type Natriuretic Peptide Monitoring With Kidney Failure in Patients With CKD: A Cohort Study.
    Oka T, Sakaguchi Y, Hattori K, Asahina Y, Kajimoto S, McCallum W, Tighiouart H, Sarnak MJ, Kaimori JY, Isaka Y.
    Am J Kidney Dis; 2023 Nov 07; 82(5):559-568. PubMed ID: 37354935
    [Abstract] [Full Text] [Related]

  • 15. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
    Silva AP, Mendes F, Carias E, Gonçalves RB, Fragoso A, Dias C, Tavares N, Café HM, Santos N, Rato F, Leão Neves P, Almeida E.
    Int J Mol Sci; 2019 Mar 27; 20(7):. PubMed ID: 30934737
    [Abstract] [Full Text] [Related]

  • 16. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
    Zhan M, Doerfler RM, Xie D, Chen J, Chen HY, Diamantidis CJ, Rahman M, Ricardo AC, Sondheimer J, Strauss L, Wagner LA, Weir MR, Fink JC, CRIC Study Investigators.
    Am J Kidney Dis; 2020 Aug 27; 76(2):184-193. PubMed ID: 32317121
    [Abstract] [Full Text] [Related]

  • 17. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
    Lash JP, Ricardo AC, Roy J, Deo R, Fischer M, Flack J, He J, Keane M, Lora C, Ojo A, Rahman M, Steigerwalt S, Tao K, Wolf M, Wright JT, Go AS, CRIC Study Investigators.
    Am J Kidney Dis; 2016 Oct 27; 68(4):545-553. PubMed ID: 27209443
    [Abstract] [Full Text] [Related]

  • 18. Ultraprocessed Foods and Kidney Disease Progression, Mortality, and Cardiovascular Disease Risk in the CRIC Study.
    Sullivan VK, Appel LJ, Anderson CAM, Kim H, Unruh ML, Lash JP, Trego M, Sondheimer J, Dobre M, Pradhan N, Rao PS, Chen J, He J, Rebholz CM, CRIC Study Investigators.
    Am J Kidney Dis; 2023 Aug 27; 82(2):202-212. PubMed ID: 37028638
    [Abstract] [Full Text] [Related]

  • 19. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI, CRIC Study Investigators.
    Am J Kidney Dis; 2014 Feb 27; 63(2):236-43. PubMed ID: 24182662
    [Abstract] [Full Text] [Related]

  • 20. Frailty and Cardiovascular Outcomes in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Hannan M, Chen J, Hsu J, Zhang X, Saunders MR, Brown J, McAdams-DeMarco M, Mohanty MJ, Vyas R, Hajjiri Z, Carmona-Powell E, Meza N, Porter AC, Ricardo AC, Lash JP, CRIC Study Investigators.
    Am J Kidney Dis; 2024 Feb 27; 83(2):208-215. PubMed ID: 37741609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.